Production (Stage)
Protalix BioTherapeutics, Inc.
PLX
$1.58
$0.063.95%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.74M | 34.83M | 27.41M | 45.03M | 48.49M |
| Total Receivables | 4.68M | 3.40M | 2.20M | 10.13M | 3.76M |
| Inventory | 19.51M | 21.24M | 17.20M | 20.72M | 22.35M |
| Prepaid Expenses | -- | 500.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.59M | 110.00K | 1.05M | 1.49M | 812.00K |
| Total Current Assets | 60.51M | 60.08M | 47.85M | 77.37M | 75.40M |
|
|
|||||
| Total Current Assets | 60.51M | 60.08M | 47.85M | 77.37M | 75.40M |
| Net Property, Plant & Equipment | 9.95M | 10.02M | 10.29M | 10.34M | 10.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.43M | 3.32M | 3.42M | 3.83M | 3.76M |
| Total Assets | 73.89M | 73.42M | 61.56M | 91.54M | 89.83M |
|
|
|||||
| Total Accounts Payable | 4.12M | 4.53M | 3.14M | 4.06M | 3.15M |
| Total Accrued Expenses | 14.87M | 13.80M | 11.88M | 13.30M | 12.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.43M | 1.50M | 1.51M | 21.87M | 21.87M |
| Total Finance Division Other Current Liabilities | 3.90M | 5.79M | 7.70M | 18.74M | 16.92M |
| Total Other Current Liabilities | 3.90M | 5.79M | 7.70M | 18.74M | 16.92M |
| Total Current Liabilities | 24.32M | 25.62M | 24.22M | 57.97M | 54.83M |
|
|
|||||
| Total Current Liabilities | 24.32M | 25.62M | 24.22M | 57.97M | 54.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.81M | 4.03M | 4.18M | 4.28M | 4.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 551.00K | 559.00K | 730.00K | 705.00K | 712.00K |
| Total Liabilities | 28.68M | 30.21M | 29.13M | 62.96M | 60.04M |
|
|
|||||
| Common Stock & APIC | 427.22M | 421.60M | 417.32M | 416.70M | 415.71M |
| Retained Earnings | -382.01M | -378.39M | -384.89M | -388.12M | -385.92M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 45.21M | 43.21M | 32.44M | 28.58M | 29.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.21M | 43.21M | 32.44M | 28.58M | 29.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.21M | 43.21M | 32.44M | 28.58M | 29.79M |
|
|
|||||